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Omega-3 polyunsaturated fatty acids (PUFAs) are essential nutrients well known for their beneficial effects, among others on cognitive development and
maintenance, inflammation and oxidative stress. Previous studies have shown an inverse association between high plasma levels of PUFAs and age-related
hearing loss, and the relationship between low serum folate and elevated plasma homocysteine levels and hearing loss. Therefore, we used C57BL/6J mice and
long-term omega-3 supplementation to evaluate the impact on hearing by analyzing their auditory brainstem response (ABR) and distortion product otoacoustic
emissions (DPOAE) thresholds. The omega-3 group showed significantly lower ABR hearing thresholds (~25 dB sound pressure level) and higher DPOAE
amplitudes in mid–high frequencies when compared to the control group. These changes did not correlate with alterations between groups in plasma
homocysteine or serum folate levels as measured by high-performance liquid chromatography and a microbiological method, respectively. Aging in the control
group was associated with imbalanced cytokine expression toward increased proinflammatory cytokines as determined by quantitative reverse transcriptase
polymerase chain reaction; these changes were prevented by omega-3 supplementation. Genes involved in homocysteine metabolism showed decreased
expression during aging of control animals, and only alterations in Bhmt and Cbswere significantly prevented by omega-3 feeding. Western blotting showed that
omega-3 supplementation precluded the CBS protein increase detected in 10-month-old controls but also produced an increase in BHMT protein levels.
Altogether, the results obtained suggest a long-term protective role of omega-3 supplementation on cochlear metabolism and progression of hearing loss.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The functional decline of the organism during aging is associated
with the onset of a variety of chronic illnesses, including cancer,
diabetes, atherosclerosis, osteoporosis and cardiovascular disease
[1,2]. Aging is also associated with a progressive sensory impairment
that is often concomitant with cognitive decline [1,3,4]. Most chronic
diseases share common biochemical alterations leading to cellular
degeneration and organ malfunction [2]. Treatment of all these
disorders represents a key health challenge but also a major
socioeconomic problem because, for example, the population over
65 years will presumably double by 2050 in the European Union [5].⁎ Corresponding author. Instituto de Investigaciones Biomédicas “Alberto
Sols” (CSIC-UAM), Arturo Duperier 4, 28029, Madrid, Spain. Tel.: +34
915854414; fax: +34 915854401.
E-mail address: mapajares@iib.uam.es (M.A. Pajares).
1 These authors share senior authorship.
http://dx.doi.org/10.1016/j.jnutbio.2015.07.011
0955-2863/© 2015 The Authors. Published by Elsevier Inc. This is an open access article under theTherefore, biomedical research is focusing in the understanding of the
genetic andmolecularmechanisms underlying aging and in the design
of new strategies to promote active and healthy aging, including
nutritional intervention.
Hearing loss is one of the ﬁelds in which nutrition intervention
studies may have more preventive potential, especially age-related
hearing loss (ARHL). Approximately 30% of the population over 65
years suffers ARHL, its incidence increasing exponentially with age
[6,7]. Worldwide epidemiological studies have shown an association
between deﬁciencies in several essential nutrients and hearing loss
[8–12].Moreover, other studies also provided evidences of its putative
prevention by dietary supplementation with folic acid [13] or due to
different levels of n-3 polyunsaturated (ω3) fatty acids (PUFAs) in the
diet [14–17]. The general basis for this protection seems to rely on the
relationship between vascular disease and hearing loss, which was
suggested initially by the lack of presbycusis and cardiovascular
disease in theMabaan tribe and further supported by several studies in
search of a correlation between cardiovascular events and hearing lossCC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lying cause for the atrophy of the stria vascularis [20,23], which is the
structure within the cochlea that maintains its metabolic and ionic
homeostasis [24]. Animal models of AHRL have provided further
information on its etiology. Thus, for example, the gerbil also presents
progressive blood ﬂow reduction and microvascular alterations at the
stria vascularis and spiral ligament associated with hearing loss and
aging [25,26]. Altogether, these data suggest that a reduction in the
blood supply of essential nutrients into the cochlea, and the
subsequent metabolic alterations, could be among the main triggers
of hearing loss progression.
High levels of plasma homocysteine (tHcy), a keymetabolite of the
folate and methionine cycles [27], are considered an independent risk
factor for cardiovascular disease [28] and, more recently, also of
human hearing loss [12,13]. Vascular diseases are also closely related
to inﬂammation, a condition ameliorated by supplementationwithω3
fatty acids [29,30]. These relationships were the basis for the limited
number of studies on the effects of ω3 supplementation on hearing
loss and Hcy metabolism carried out to date. These studies showed an
inverse correlation between the ingested levels of long-chainω3 fatty
acids and hearing loss [15,16], but opposite effects on tHcy resulted
from ﬁsh oil supplementation [31,32]. Dissimilar results on tHcy and/
or auditory brainstem response (ABR)were also obtained from animal
studies of ω3 supplementation carried out for limited time periods in
adults or during pregnancy and lactation [33–37]. Therefore, the
urgent need of a better knowledge of hearing loss progression and the
potential of dietary components to prevent and/or delay its onset led
us to use a classical model of early hearing loss, the C57BL/6J mice, to
carry out a detailed follow-up of the auditory capacity in long-termω3
supplementation. Altogether, our results show that ω3 supplementa-
tion attenuated progression of hearing loss, this maintenance of
function associating with differences in cochlear Hcy metabolism and
in the balanced ratio of anti- and proinﬂammatory biomarkers.
2. Materials and methods
2.1. Mouse handling and experimental design
Seven-week-old C57BL/6J female mice [38,39] were purchased from Charles River
Laboratories (Hollister, CA, USA) and housed under standard conditions. After an
acclimatization period of 1 week, these 2-month-old mice were randomly divided into
two experimental groups that were fed for 8 months either control (C-10M; n=15) or
ω3-supplemented (ω3-10M; n=9) diets ad libitum. A group of mice within those
receiving the control diet was sacriﬁced at 4 months of age for comparative purposes
(C-4M; n=4). The composition of both semisynthetic diets was adjusted to mice
requirements in full accordance with National Research Council directives [40], with
modiﬁcations affecting only the fat content (Table 1). The AIN-93M-MX mineral mix
(TD.94049) and the AIN-93-VX vitamin mix (TD.94047) used for diet preparation were
purchased from Harlan Teklad (Indianapolis, IN, USA), whereas the ﬁsh oil Eupoly-3™
eicosapentaenoic acid (EPA)was gently supplied by Biosearch SA (Granada, Spain). Diet
pellets were freshly made at the onset of the experiment and stored at −20°C in
portions of the appropriate size until use; thawing was carried out at 4°C, and new
pellets were provided every other day. Animals were weighted weekly andmaintained
on a 12-h:12-h dark/light cycle under controlled temperature and humidity conditionsTable 1
Diet composition
Control diet (g/kg) ω-3 diet (g/kg)
Cornstarch 620.7 620.7
Casein (≥85%) 140.0 140.0
Cellulose 50.0 50.0
Saccharose 100.0 100.0
Mineral mix 35.0 35.0
Vitamin mix 10.0 10.0
L-Cysteine 2.5 2.5
Choline 2.5 2.5
tert-Butylhydroquinone 0.008 0.008
Soybean oil 40.0 38.4
Fish oil Eupoly-3™ EPA – 1.6at the facilities of the Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM).
All experiments were approved by the CSIC Bioethics Committee and carried out in full
accordance with the European Union (2010/63/EU) and Spanish regulations (RD 53/
2013) for the use of laboratory animals.2.2. Hearing assessment
Hearing was evaluated at the beginning of the experiment (2 months of age) and
monthly from 4 months of age onward (Fig. 1). Mice were anesthetized with ketamine
(100 mg/kg) and xylazine (10 mg/kg), and the ABR was recorded for hearing
assessment as previously described [41,42]. Brieﬂy, broadband click and pure tone
frequencies were recorded at 4, 8, 16, 20, 28 and 40 kHz at an intensity range from 90 to
10 dB sound pressure level (SPL) in 5–10-dB steps. The electrical responses were
ampliﬁed and averaged to determine hearing thresholds for each stimulus. Peak and
interpeak latencies were analyzed at 15–20-dB SPL above hearing threshold after click
stimulation. Animals were kept thermostatized and monitored during both anesthesia
and the following period of recovery. The anesthetics used in the present work are
known to be metabolized in the liver and kidney within 24 h.
The recording of distortion product otoacoustic emissions (DPOAEs) was
performed after stimulation with f1 and f2 primary tones, with a ratio f2/f1=1.2. An
Etymotic ER-10B+™ probe was used for the generation of f1 and f2 and sound
capturing. The calibration of the probe for determining the degree of attenuation of the
primary frequencies was performed using a sound-attenuating cylinder with known
volume (i.e., 1-ml syringe) to simulate the mouse ear canal with the aid of the TDT
equipment, as described previously [43,44]. Primary tones for 8-, 10-, 14-, 18- and 22-
kHz frequencies were tested. Decreasing intensity steps of 5–10 dB were performed
from 80 to 30 dB SPL for each pair of frequencies (150 averages per intensity).
Simultaneously, the probe was connected to a 100–50,000-μV ampliﬁer, and the signal
processing and subsequent analysiswere carried outwith the help of softwareBioSigRP™.
The 2f1-f2 DPOAE component was considered positive when exceeding 5 dB SPL above
background noise, this being calculated as the average amplitude of ﬁve randomly chosen
points on both sides of the 2f1-f2 component. All the frequencies usedwere generated by
SigGenRP™ (Tucker Davis Technologies TDT, Alachua, FL, USA).2.3. Cochlea extraction and processing
Mice were sacriﬁced by CO2 asphyxiation for tissue removal at 4 and 10 months of
age. Tissues were immediately frozen in liquid nitrogen for protein or RNA extraction.
Blood samples were collected by cardiac puncture and placed in regular or heparin-
coated tubes (Laboratorios Farmacéuticos Rovi, Madrid, Spain). After centrifugation at
2500×g for 10 min, the corresponding serum or plasma fractions were isolated and
stored at−80°C until use.2.4. Metabolite determinations
Total plasma Hcy (tHcy) was determined after derivatization using the Reagent kit
for the high-performance liquid chromatography analysis of Hcy in plasma/serum
(Chromsystems Instruments & Chemicals GMBH, Munich, Germany) following
manufacturer’s instructions. Serum folate levels were analyzed by a microbiological
method using Lactobacillus casei (American Type Culture Collection; ATCC 7469) [45],
as modiﬁed by Tamura [46].Fig. 1. Scheme of the experimental procedure. Mice were fed a standard diet until they
became 2 months old (n=24). At this age, ABR analysis was performed, and mice were
randomly divided into two experimental groups receiving the standard (control; n=
15) or the ω3-supplemented diets (ω3; n=9). From 4 months of age onward, ABR was
performedmonthly, and samplingwas carried out at 4 (only in the control group, C-4M;
n=4) and 10 months of age (C-10M and ω3-10M). ABR analysis is represented by
triangles, and sampling is indicated by a blue (control) or red “X” symbol (ω3
supplemented); points of detailed biochemical analysis are indicated by arrows.
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Whole cochlear protein was prepared using the ReadyPrep™ Protein Extraction kit
for total protein (Bio-Rad, Hercules, CA, USA). Protein concentration was determined
using the RC DC™ Protein Assay kit (Bio-Rad) and bovine serum albumin as standard.
Samples (100 μg) were loaded into Mini-PROTEAN TGX™ 10% precast polyacrylamide
gels (Bio-Rad) and electrotransferred to polyvinylidene diﬂuoride membranes (Bio-
Rad) with the Trans-Blot Turbo™ transfer starter system (Bio-Rad) for incubation with
the appropriate antibodies (Table 2). Signals were developed using Clarity™Western
ECL Substrate (Bio-Rad), captured using ImageQuant™ LAS4000 mini system (GE
Healthcare, Buckinghamshire, UK) and quantiﬁed with the ImageQuant™ TL software
(GE Healthcare) as previously reported [47]. Values were normalized against β-actin
signals, and mean values for the C-4M controls were considered as 100%.
2.6. Real-time reverse transcriptase polymerase chain reaction (RT-PCR)
Total cochlear RNAwas isolated using the RNeasy kit (Qiagen, Hilden, Germany), its
quality and quantity determined on a Bioanalyzer 2100 (Agilent Technologies, Santa
Clara, CA, USA). Reverse transcription and PCR were done as previously described
[48,49]. cDNAs (10 ng) were ampliﬁed in triplicate using gene-speciﬁc primers
(Table 3) and Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA,
USA) or TaqMan probes (Cat, Gss, O3fa1, Il6, Il1b, Tnfa, Il10, Igf1, Igf1r, Tgfb1 and Tgfb1r)
using the ABI 7900HT-Real-Time PCR System (Applied Biosystems). Relative expression
ratios were normalized to the geometric mean of the Rn18s or the Rplp0 genes and the
fold changes calculated [50,51].
2.7. Statistical analysis
The IBM statistics SPSS v22 software package (Chicago, IL, USA) was used for
statistical analysis. Statistical signiﬁcance was determined by Student’s t test for
unpaired samples (C-10M vs. ω3-10M) or by one-way analysis of variance with
Bonferroni post hoc test when the C-4M control set was also included in the analysis. All
results are expressed as themean±standard error of themean (S.E.M.), and differences
were considered signiﬁcant when P≤.05.
3. Results
3.1. Body weight and food intake
Initially, the average daily food intakewas signiﬁcantly lower in the
ω3-supplemented group than in the control group (4.12±0.11g vs.
4.70±0.22 g; P=.03), but this parameter became similar from 10Table 2
Antibodies used in this study
Primary antibody Source Dilution (v/v
Mouse anti-phospho-SAPK/JNK Cell Signaling (9255) 1:2000
Rabbit anti-SAPK/JNK Cell Signaling (9252) 1:1000
Rabbit anti-phospho-p42/44 MAPK (ERK 1/2) Cell Signaling (9101) 1:1000
Rabbit anti- p42/44 MAPK (ERK 1/2) Cell Signaling (9102) 1:1000
Rabbit anti-p38α Santa Cruz (sc-535) 1:1000
Rabbit anti-phospho-p38 MAP kinase Cell Signaling (9211) 1:1000
Mouse anti-β-actin Sigma (A5441) 1:5000
Mouse anti-CBS Abnova (H00000875-A01) 1:3000
Rabbit anti-BHMT González et al. a 1:5000
Rabbit anti-ADK Abcam (ab88903) 1:1000
Rabbit anti-Hcy Chemicon-Millipore (AB5512) 1:1000
Goat anti-AHCY Santa Cruz (sc-55759) 1:500
Goat anti-MTR Abnova (PAB6022) 1:100
WB, Western blotting.
a Gonzalez B, Campillo N, Garrido F, Gasset M, Sanz-Aparicio J, Pajares MA. Active-site-m
2003;370:945–52.weeks onward (4.52±0.15 g vs. 4.80±0.04 g; PN.05). No differences
in weight gain were observed along the study between control and
ω3-supplemented groups. At the end point of the study, animals in
the two dietary groups, C-10M and ω3-10M, showed normal weight
values (24.6±0.9 g vs. 23.3±0.6 g; PN.05) according to the strain
characteristics [52].
3.2. Progression of sensorineural hearing loss
Hearing was assessed along the study, the ﬁnal end point being 10
months of age (Fig. 1). ABR thresholds, wave amplitudes and latencies
remained similar at 7 months of age in control andω3-supplemented
groups (Fig. 2A). Nonetheless, DPOAE analysis showed a signiﬁcant
decrease in the 2f1-f2 amplitude at 8 kHz for the control group when
measured at intensities of 20 dB SPL above threshold (Fig. 2B).
Damage was more evident at 10 months of age, where ω3-10M
mice showed signiﬁcant decreases in the ABR thresholds at several
frequencies as compared to the C-10M group (Fig. 3A). Precisely, ABR
thresholds in response to 4-, 8- and 40-kHz frequencies declined 27 dB
SPL (Pb.001), 16 dB SPL (P=.02) and 17 dB SPL (P=.027), respectively
(Fig. 3A). Age-related changes in the ABR waves include a decrease in
their amplitudes together with an increase on their latencies. There
were no statistical differences between both groups in the click ABR
wave analysis of latencies and interpeak latencies. However, ω3-10M
mice showed a smaller decrease in wave I amplitude along with a
decrease in its latency (Fig. 3B–C) when compared to the C-10M
group. Moreover, a mild and nonsigniﬁcant progressive delay in wave
IV latencywas shown in the C-10M group comparedwith theω3-10M
mice (Fig. 3B–D).
3.3. Effects in cytokine expression and stress biomarkers
Quantitative RT-PCR (RT-qPCR) was used to determine putative
changes in several genes involved in inﬂammation and stress
pathways (Fig. 4). Comparison of C-4M and C-10M cochleae showed
signiﬁcant decreases in expression levels of the anti-inﬂammatory) Secondary antibody Source Dilution (v/v) Technique
IgG sheep anti-mouse HRP conjugated GE Healthcare
(NA931)
1:3000 WB
IgG goat anti-rabbit HRP conjugated Bio-Rad
(170-6515)
1:3000 WB
IgG goat anti-rabbit HRP conjugated Bio-Rad
(170-6515)
1:3000 WB
IgG goat anti-rabbit HRP conjugated Bio-Rad
(170-6515)
1:3000 WB
IgG goat anti-rabbit HRP conjugated Bio-Rad
(170-6515)
1:3000 WB
IgG goat anti-rabbit HRP conjugated Bio-Rad
(170-6515)
1:3000 WB
IgG sheep anti-mouse HRP conjugated GE Healthcare
(NA931)
1:20000 WB
IgG sheep anti-mouse HRP conjugated GE Healthcare
(NA931)
1:2500 WB
IgG goat anti-rabbit HRP conjugated Bio-Rad
(170-6515)
1:5000 WB
IgG goat anti-rabbit HRP conjugated Bio-Rad
(170-6515)
1:10000 WB
IgG goat anti-rabbit HRP conjugated Bio-Rad
(170-6515)
1:3000 WB
IgG donkey anti-goat HRP conjugated Santa-Cruz
(sc-2020)
1:3000 WB
IgG donkey anti-goat HRP conjugated Santa-Cruz
(sc-2020)
1:3000 WB
utagenesis study of rat liver betaine-homocysteine S-methyltransferase. Biochem J
Table 3
SYBR Green primers used in real-time RT-PCR experiments
Gene Basesa Forward primer (5’-3’)b Bases Reverse primer (5’-3’) nMd
Ada 641–663 GGGATGAGACCATTGAAGGAAGT 709–689 TCTTTACTGCGCCCTCATAGG 300
Adk c 883–903 AGAGGCAGAGGACCGTGATCT 946–925 TCATTCTCTGCAGCCACTATGG 300
Bhmt 672–692 CAGAATTCCCCTTTGGATTGG 742–721 GGCCTCTCTGGCATATTTTTGA 300
Cbs c 1274–1292 GCAGCGCTGTGTGGTCATC 1337–1312 GTCACTCAGGAACTTGGACATGTAGT 300
Ahcy 1531–1554 TCGAAGTGTCCAATGTTACAGACA 1592–1575 CTTGGCCGGCACTTTGAG 300
Mtr 2006–2026 CGCGATCAAGTTTGGTATGGA 2080–2057 TCCTTGTGGATAGCATCATACACA 300
Cth c 190–212 CAGTCCTCGGGTTTTGAATACAG 260–241 GCAGCCACTGCTTTTTCCAA 300
Rn18s 1645–1666 CCAGTAAGTGCGGGTCATAAGC 1737–1716 CCTCACTAAACCATCCAATCGG 100
a Base numbers indicate the location of the primer sequences in the corresponding mRNA.
b Primers were previously described byMartínez-Vega et al. [49] except for Cth primers that were designed for this study using the Program Primer Express 3.0 and the mouse gene
sequence with reference NC_000069.6.
c Primers for Cbs, Cth and Adk were designed in regions common to the several splicing forms reported.
d Primer concentrations used for SYBR Green detection.
1427R. Martínez-Vega et al. / Journal of Nutritional Biochemistry 26 (2015) 1424–1433cytokine Il10, as well as in Igf1 and in the Igf1r receptor (Pb.05;
Fig. 4A). On the other hand, proinﬂammatory cytokines Il1b and Il6
exhibited higher expression levels in C-10M than in C-4M cochleae
(Pb.05; Fig. 4A). These expression changeswere partially prevented in
ω3-10M because Igf1 and Igf1r mRNA levels increased signiﬁcantly,Fig. 2. Hearing evaluation in 7-month-old mice. (A) ABR thresholds in response to click and ton
experiment) and 7 months of age. (B) DP thresholds (dB SPL) in response to 8-, 10-, 14-, 18- a
months of age. (C) 2f1-f2 amplitudes (nV) in response to 8-, 10-, 14-, 18- and 22-kHz primary to
are shown as the mean±S.E.M. Statistical signiﬁcance: **Pb.01.whereas Il1b and Il6 expression levels decreased as compared to
C-10M cochleae (Pb.05). In fact, expression values in ω3-10M were
comparable to those obtained in C-4M cochleae. Additionally, the
supplementation produced a signiﬁcant increase in Tgf1br expression
as compared tomatched C-10M cochleae (Pb.05), whereas no changese burst stimuli in control (blue) andω3-supplemented (red) mice at 2 (beginning of the
nd 22-kHz primary tones in control (blue) and ω3-supplemented (red) mice at 2 and 7
nes in control (blue) andω3-supplemented (red)mice at 2 and 7months of age. Results
Fig. 3. Hearing evaluation in 10 month-old mice. (A) ABR thresholds in response to click and tone burst stimuli in control (blue; n=5) and ω3-supplemented (red; n=6) mice at 2
(beginning of the experiment) and 10months of age. (B) Scheme of the auditory pathway adapted fromMurillo-Cuesta et al. [42] indicating themain structures and their corresponding
ABRwaves: (I) auditory nerve, (II) cochlear nucleus, (III) superior olivary nucleus, (IV) lateral lemniscus and (V) inferior colliculus. (C)Wave I andwave IV latency–intensity functions at
2 and 10 months of age. Data are shown as the mean±S.E.M. Statistical signiﬁcance: **Pb.05, *** Pb.001.
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the cochlear expression levels of the fatty acid transporter O3fa1
were evaluated along the study, but no differences between groups
were observed.
Key elements involved in stress signaling pathways were also
studied by Western blotting (Fig. 4B). No signiﬁcant changes in ERK
phosphorylation were detected among groups, whereas JNK phos-
phorylation levels were lower inω3-10M than in the C-10M cochleae
(P=.017). Both C-10M and ω3-10M cochleae exhibited increasedlevels of p38α phosphorylation as compared to the C-4M samples (P=
.024). Additionally, signs of oxidative stress were found when C-4M
and C-10M cochleae were compared, as judged by the changes
detected by RT-qPCR in appropriate biomarkers (Fig. 4C). Cat
expression levels were reduced ~40% in C-10M as compared to C-4M
control cochleae and a similar decreasewas detected inGss expression
levels. These changes were partially prevented in ω3-10M cochleae,
which exhibited values of Cat andGss expression approaching those of
C-4M mice.
Fig. 4. Evaluation of inﬂammation and oxidative stress markers. (A) Cochlear expression levels of genes related to inﬂammation and insulin signaling in mice receiving control (C-4M
and C-10M) orω3-supplemented diets (ω3-10M) at 4 (C-4M) or 10 months of age (C-10M andω3-10M). Rn18s and Rplp0 genes were used as the endogenous housekeeping controls.
(B) Protein levels of phospho-p38 (P-p38), phospho-JNK (P-JNK) and phospho-ERK (P-ERK) stress kinases measured byWestern blotting using p38α, ERK 1/2 and JNK as total protein
controls. (C) Evaluation of cochlear expression levels for Cat and Gss genes in mice fed control (C-4M and C-10M) orω3-supplemented diets (ω3-10M) using Rn18s and Rplp0 genes as
endogenous housekeeping controls. Mean data of the C-4M group are presented as 100% for graphical purposes. Values are presented as themean±S.E.M. for each group: C-4M (n=4),
C-10M (n=6), ω3-10M (n=6). Statistical signiﬁcance: *Pb.05, **Pb.01.
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At the end point of the study, no signiﬁcant changes in tHcy [3.56±
0.71 (n=4) vs. 3.22±0.53 μM (n=6); PN.05] or serum folate levels
[45.02±9.95 (n=5) vs. 32.36±2.83 μg/L (n=6); PN.05] were detected
between C-10M and ω3-10M groups. Systemic levels may not reﬂect
changes taking place in cochlear Hcy metabolism given the small size
of the organ and the low expression levels of cochlear Hcymetabolism
enzymes. Hence, putative alterations in expression of genes involved
in this metabolic pathway were analyzed by RT-qPCR (Fig. 5A).
Comparison between the C-4M and C-10M cochleae showed that
aging induced signiﬁcant reductions in the expression of Ahcy, Adk,Bhmt,Mtr, Cbs and Cth genes (Pb.05), whereas Ada expressionwas not
affected. Only the decreased levels of Bhmt and Cbs transcripts were
signiﬁcantly prevented in ω3-10M cochleae (Pb.05); the expression
values of these genes remained similar to those in the C-4M cochleae.
Moreover, supplementation with ω3 also led to a signiﬁcant decrease
in Ada expression as compared to that shown in C-10M cochleae. In
general, a tendency towards preservation of mRNA levels similar to
those in Hcy metabolism of C-4M cochleae was detected after 8
months of ω3-supplementation.
Effects on cochlear Hcy metabolism were also measured by
Western blotting (Fig. 5B–C). Comparison between C-4M and C-10M
cochleae showedno signiﬁcant changes in BHMT (68 kDa in this tissue
Fig. 5. Analysis of changes in cochlear homocysteine metabolism. (A) Alterations in mRNA expression levels of Ahcy, Mtr, Bhmt, Cbs, Cth, Adk and Ada analyzed by RT-qPCR using the
Rn18s gene as the endogenous control. Sample groups are shown according to the diet received and themice age as 4-month-old controls (C-4M, n=4), 10-month-old controls (C-10M,
n=8) andω3 supplemented (ω3-10M, n=6). (B) Representative images of ADK, BHMT, MTR, AHCY and CBS protein levels measured byWestern blotting using β-actin as the loading
control; histograms show the densitometric analysis of the data. (C) Representative images of antihomocysteine Western blotting and the corresponding densitometric analysis of the
results. Mean data of the C-4M group are presented as 100% for graphical purposes. Values are presented as the mean±S.E.M. for each condition: C-4M (n=4), C-10M (n=6),ω3-10M
(n=6). Statistical signiﬁcance: *Pb.05, **Pb.01, *** Pb.001.
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due to the aging process, whereas the joint levels of both CBS splicing
forms increased signiﬁcantly in the C-10M cochleae. Fatty acid
supplementation did not alter MTR, AHCY and ADK protein levels in
ω3-10M cochleae as compared to both C-4M and C-10M groups butinduced a signiﬁcant increase in BHMT levels as compared to C-10M
cochleae. In contrast, ω3-10M showed CBS protein levels similar to
those in C-4M cochleae and signiﬁcantly lower than those detected in
C-10M samples. These data suggested a putative enhancement of Hcy
intracellular levels and hence in protein homocysteinylation.
1431R. Martínez-Vega et al. / Journal of Nutritional Biochemistry 26 (2015) 1424–1433However, examination by Western blotting of cochlear extracts using
anti-Hcy showed no signiﬁcant changes in global protein homocys-
teinylation levels between cochleae of the different animal groups
(Fig. 5C).
4. Discussion
Progressive hearing loss is a major part of the age-related sensory
impairment, which shares common molecular mechanisms with
many other age-related chronic diseases, including diabetes and
cardiovascular disorders [1,2,53,54]. Among them, increased inﬂam-
mation, impairment of insulin signaling, abnormal proteostasis,
oxidative stress and alterations in intermediary metabolism have
been reported [41,49,53–56], and hence targeting these traits may
offer opportunities to slow down progression of hearing loss. Long-
chain ω3 PUFAs, which have demonstrated anti-inﬂammatory
properties, may provide this type of intervention through changes in
nutritional patterns as deduced from epidemiological studies [15]. In
fact, the loss of hearing acuity observed in C-10M mice was partially
prevented inω3-10M animals, this reproducible effect being however
of limitedmagnitude. One potential reasonmay rely on the use of EPA-
rich ﬁsh oil, instead of a more equilibrated formulation of EPA and
docosahexaenoic acid (DHA). However, EPA is known to be more
effective than DHA in reducing inﬂammation [57], and indeed Il1b, Il6
and Il10 expression levels in ω3-10M were similar to those in C-4M
cochleae. Detection of increased expression and/or levels of proin-
ﬂammatory cytokines during aging is a change not unique to the
C57BL/6J strain but also detected in, for example, senescence-
accelerated resistant (SAMR) mice in which hearing loss and
inﬂammation are shown at similar ages [58]. However, SAMR mice
show increased levels of TNFα, whereas Tnfa expression in C-10M is
not signiﬁcantly enhanced or modiﬁed by ω3-supplementation. Such
differencemay in turn rely on themoderate signs of cochlear oxidative
stress observed in C-10M, which is a key determinant for the
production of proinﬂammatory cytokines.
Circulating levels of IGF-1 are reduced with age in mammals
[55,59], and its low levels correlatewith different types of hearing loss
and presbycusis [56]. Igf1-null mice develop hearing loss affecting the
number of cochlear neurons, the degree of innervation of the hair cells
and also the stria vascularis, in turn, the main metabolic structure of
the cochlea [55]. Reduced expression of Igf1 and its receptor Igf1rwas
therefore expected, and conﬁrmed, in C-10M cochleae. Maintenance
or recovery of IGF-1 levels byω3-supplementation, especially EPA, has
been demonstrated in several epidemiological studies and animal
models of acute or chronic pathologies [60–62]. In this line of evidence,
our study shows that ω3-10M cochleae preserve the Igf1 and Igf1r
expression levels shown in C-4M cochleae and hence no signs of
impairment in insulin signaling. IGF-1 deﬁciency in the mouse causes
an all-frequency neurosensorial deafness and neural loss [41,63,64]. In
contrast, here we report that ω3-10M mice show lower thresholds
than C-10M mice only at speciﬁc scattered frequencies. This result
suggests that there is a general improvement in hearing upon ω3
supplementation, with differences registered in some frequencies
reaching statistical signiﬁcance. Cochlear stress pathways are activat-
ed in response to proinﬂammatory cytokines and oxidative stress,
among others in noise-induced hearing loss, as a consequence of
aging, and in Igf1-null mice [56,65–67]. This behavior was partially
shared by C-10Mmice,which presentedwith increased phospho-p38/
p38 ratios but lack signiﬁcant activation of JNK or ERK. Prevention of
p38 activation was not achieved in ω3-10M cochleae, which in
contrast showed decreased phospho-JNK/JNK levels. Although ω3
supplementation has proved its ability to decrease IL-6 and IL-1β
levels together with the activation of stress pathways in several
experimental settings [68,69], this does not seem to be the case in our
model of hearing loss progression, the difference relying possibly inthe trigger of hearing loss, cisplatin [69] versus age in our study.
Activation of the p38 signaling pathway has also been described in
cortical neurons grown in the presence of Hcy, a metabolite whose
increased levels are considered an independent risk factor for both
neurological disorders and cardiovascular disease and whose meta-
bolism is altered in hearing loss [49,70]. This Hcy-dependent
activation of p38 involves stimulation of N-methyl-D-aspartate
receptors and ERK activation [71], this last pathway remaining
essentially unaffected in C-10M and ω3-10M cochleae in which the
contribution of the neuronal population is limited by the presence of
other cell types. Inﬂammation is generally secondary to oxidative
stress, as a consequence of increased free oxygen and nitrogen radical
generation in the sensory cells, neurons and stria vascularis.
Accumulative cellular damage contributes to ARHL that typically
shows the strongest alterations in the cochlear basal sensory
epithelium responsible for the perception of high frequencies
[49,72]. In contrast, treatments aimed to decrease the oxidative stress
and inﬂammatory response, secondary to cochlear injury, have shown
all-frequency protection patterns [73–75].
Alterations in Hcy metabolism due to aging seem limited in our
model. First, no signiﬁcant changes in systemic tHcy or folate levels are
detected in C-10Mmice as compared to those previously reported for
4-month-old animals on a control diet [49]. Second, although
reductions in expression levels of genes involved in cochlear Hcy
metabolism were detected at 10 months of age, these changes had a
limited effect in protein levels. In fact, only CBS protein levels
increased in C-10M cochleae, suggesting an enhanced ﬂux through
the transsulfuration pathway. These differences between steady-state
levels of several proteins and their mRNAs can be ascribed to changes
in their half-lives that take place, for example, during oxidative stress,
as demonstrated previously in hepatoma cell lines [76]. Increased
levels of CBS might be required to synthesize higher levels of H2S
rather than for cysteine production given the ability of the former to
differentially regulate the synthesis of anti- and pro-oxidant enzymes
and anti- and proinﬂammatory mediators [77–79]. In fact, several
synthetic drugs with capacity to act as H2S providers have been used
for the treatment of hearing loss with diverse results [80,81].
The supplementation with ω3 fatty acids used in the present study
did not induce changes in tHcy or folate levels, as previously reported in
short-term supplementation studies in rats [36,37]. However, the
supplementationwas able to reduce Ada expression in C-10M cochleae,
a protein with undetectable levels in 4-month-old mice [49], hence
further favoring adenosine elimination through ADK, themain enzyme
responsible for this role in the cochlea [82]. Moreover, the supplemen-
tation prevented the decrease in Bhmt and Cbs expression in ω3-10M
cochleae, but this change led to opposite effects at the protein level.
Thus, while the speciﬁc 68-kDa BHMT band detected in cochlea [49]
increased its levels dramatically, a strong decrease in CBS protein
towards levels of C-4M controls was detected. No comparison with
other ω3 supplementation studies is possible given that the few
published reports analyzing effects on hearing loss did not evaluate
cochlearHcymetabolism[33,34].Hence, the results available refer to rat
liver or human hepatomaHepG2 cells, where no changes in Cbs, Ahcy or
Mtr expression, or in CBS and AHCY activities, were observed after
supplementation with ﬁsh oil [83] or culture in the presence of DHA,
EPA or α-linolenic acid [84]. Other short-term studies did report
elevations in hepatic expression of Bhmt and Cbs, but not in Ahcy, upon
supplementation with several long-chain ω3 fatty acids, including EPA
[36]. Some of these studies also indicated the ability ofω3 fatty acids to
regulate expression and identiﬁed fatty acid responsive elements in the
promoters of Mtr and Cbs, among other genes of the methionine cycle
[84]. This fact may also contribute to explain the opposite effects
observed in Cbs expression and protein levels in C-10M cochleae.
Changes induced by the long-term ω3 supplementation are
directed towards enhanced Hcy remethylation through methionine
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increased need of methionine can be explained by a higher
requirement of S-adenosylmethionine for methylation reactions,
including several epigenetic modiﬁcations. Such an effect has been
already observed in liver of ω3-supplemented animals, where
increased levels of methionine adenosyltransferase have been
detected [86]. This enhanced remethylation may also derive from
the incorporation of dietary ω3 fatty acids into phospholipids, their
hydrolysis to produce anti-inﬂammatory eicosanoids and related
molecules, and the resulting increase in phosphatidylcholine turn-
over. This process could render a choline excess, which, in turn, would
be oxidized to betaine, themethyl donor for BHMT [27]. The increased
expression of hepatic Gnmt and Pemt encountered in rat liver after
short-term supplementation with several ω3 fatty acids, including
EPA, points to this direction [36]. However, cochlear expression and
protein levels of these two methyltransferases, which are among the
highest consumers of S-adenosylmethionine in the liver [87], have not
been described. Phosphatidylcholine species synthesized by PEMT are
especially rich in arachidonic acid, and hence their cochlear levelsmay
be reduced in EPA supplementation toward EPA phosphatidylcholine,
as detected in measurements carried out in plasmatic phosphatidyl-
choline [88].
In summary, long-term ω3 supplementation partially prevents
progression of hearing loss in C57BL/6J mice. This effect is mainly
exerted through maintenance of IGF-1 signaling and the balance
between proinﬂammatory and anti-inﬂammatory cytokines shown in
C-4M mice. Additionally, the increased Hcy elimination through
transsulfuration observed in C-10M cochleae is compensated by the
ω3 diet through increased BHMT remethylation to preserve the ﬂux
through the methionine cycle and the protein homocysteinylation
levels within normality. However, age-related activation of the p38
stress pathway is not prevented, and hence, changes in protein
expression leading to hearing loss are still observed.
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